Literature DB >> 29767419

Association between expression of MMP-7 and MMP-9 and pelvic lymph node and para-aortic lymph node metastasis in early cervical cancer.

Hui Guo1, Yifei Dai1, Anna Wang1, Chunyan Wang1, Lili Sun2, Zheng Wang2.   

Abstract

AIMS: To investigate the association of matrix metalloproteinase (MMP)-7 and MMP-9 with pelvic lymph node and para-aortic lymph node metastasis in early cervical cancer.
METHODS: A total of 137 patients with early cervical cancer (Stage Ia2-IIa2) were recruited from the Department of Gynecology and Obstetrics, Tumor Hospital of Liaoning Province from January 2009 to May 2014. We evaluated the expression of MMP-7 and MMP-9 by immunohistochemistry and their association with the clinicopathological parameters such as pelvic, common iliac and para-aortic lymph node metastasis. Spearman correlation was performed to analyze the correlation between MMP-7 and MMP-9 in cervical cancer. Finally, the areas under the receiver operating characteristic curve (ROC) of MMP-7 and MMP-9 in pelvic lymph node metastasis were assessed.
RESULTS: MMP-7 expression was significantly higher in patients with adenocarcinomas and adenosquamous carcinomas (P = 0.014), vascular cancer embolus (P = 0.041), pelvic lymph node metastasis (P = 0.000) and a higher level of Ki-67 (P = 0.000). MMP-9 expression was significantly associated with vascular cancer embolus (P = 0.003), depth of stromal invasion (P = 0.001), pelvic lymph node metastasis (P = 0.003), common iliac lymph node metastasis (P = 0.001) and para-aortic lymph nodes metastasis (P = 0.004). Coexpression of MMP-7 and MMP-9 was significantly associated with vascular cancer embolus (P < 0.001), higher expression of Ki-67 (P < 0.001) and pelvic lymph node metastasis (P < 0.001). Spearman correlation analysis indicated a positive correlation between MMP-7 and MMP-9 (r = 0.263, P = 0.002). Areas under the ROC of MMP-7 and MMP-9 were 0.707 and 0.646, respectively.
CONCLUSION: MMP-7 and MMP-9 expressions were associated with lymph node metastasis in patients with early cervical cancers, suggesting a positive correlation of MMP-7 and MMP-9 with invasive potential in early cervical cancers.
© 2018 Japan Society of Obstetrics and Gynecology.

Entities:  

Keywords:  MMP-7; MMP-9; cervical cancer; lymph node metastasis

Mesh:

Substances:

Year:  2018        PMID: 29767419     DOI: 10.1111/jog.13659

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  9 in total

1.  Down-regulated expression of miR-99a is associated with lymph node metastasis and predicts poor outcome in stage IB cervical squamous cell carcinoma: a case-control study.

Authors:  Gongyi Zhang; Rong Zhang; Ping Bai; Shumin Li; Jing Zuo; Yuanyuan Zhang; Mei Liu; Lingying Wu
Journal:  Ann Transl Med       Date:  2022-06

Review 2.  The Impact of Matrix Metalloproteinase-9 on the Sequential Steps of the Metastatic Process.

Authors:  Giovanni Barillari
Journal:  Int J Mol Sci       Date:  2020-06-25       Impact factor: 5.923

Review 3.  Insights Into the Regulation of Gynecological Inflammation-Mediated Malignancy by Metalloproteinases.

Authors:  Yasmin Begum; Anuradha Pandit; Snehasikta Swarnakar
Journal:  Front Cell Dev Biol       Date:  2021-11-29

4.  Comprehensive analysis of lymph nodes metastasis associated genes in cervical cancer and its significance in treatment and prognosis.

Authors:  Ping Yang; Youqin Ruan; Zhiling Yan; Yang Gao; Hongying Yang; Shaojia Wang
Journal:  BMC Cancer       Date:  2021-11-16       Impact factor: 4.430

Review 5.  Approaches Toward Targeting Matrix Metalloproteases for Prognosis and Therapies in Gynecological Cancer: MicroRNAs as a Molecular Driver.

Authors:  Anuradha Pandit; Yasmin Begum; Priyanka Saha; Amit Kumar Srivastava; Snehasikta Swarnakar
Journal:  Front Oncol       Date:  2022-01-25       Impact factor: 6.244

6.  Human Plasma Levels of Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9, and Tissue Inhibitor of Matrix Metalloproteinase 1 and Their Applicability as Tumor Markers in Diagnoses of Cervical Cancer Based on ROC Analysis.

Authors:  Monika Zajkowska; Monika Zbucka-Krętowska; Iwona Sidorkiewicz; Emilia Lubowicka; Grażyna Ewa Będkowska; Ewa Gacuta; Maciej Szmitkowski; Sławomir Ławicki
Journal:  Cancer Control       Date:  2018 Jan-Dec       Impact factor: 3.302

Review 7.  The role of miRNAs in the invasion and metastasis of cervical cancer.

Authors:  Jin-Yan Wang; Li-Juan Chen
Journal:  Biosci Rep       Date:  2019-03-15       Impact factor: 3.840

8.  Up-regulation of peroxiredoxin-1 promotes cell proliferation and metastasis and inhibits apoptosis in cervical cancer.

Authors:  Ermei Lu; Xiaoli Hu; Chunyu Pan; Jingjing Chen; Yichi Xu; Xueqiong Zhu
Journal:  J Cancer       Date:  2020-01-01       Impact factor: 4.478

9.  Preoperative magnetic resonance imaging criteria for predicting lymph node metastasis in patients with stage IB1-IIA2 cervical cancer.

Authors:  Fangjie He; Shuiling Zu; Xia Chen; Jianping Liu; Ying Yi; Haijun Yang; Fuqiang Wang; Songhua Yuan
Journal:  Cancer Med       Date:  2021-07-18       Impact factor: 4.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.